Works by Fujita, Shiro


Results: 68
    1
    2
    3
    4
    5
    6
    7
    8
    9

    A Phase II Study of Pemetrexed in Chemotherapy-naïve Elderly Patients Aged ≥75 years with Advanced Non-squamous Non-small-cell Lung Cancer (HANSHIN Oncology Group 003).

    Published in:
    Japanese Journal of Clinical Oncology, 2013, v. 43, n. 12, p. 1184, doi. 10.1093/jjco/hyt159
    By:
    • Hattori, Yoshihiro;
    • Iwasaku, Masahiro;
    • Satouchi, Miyako;
    • Nishiyama, Akihiro;
    • Korogi, Yohei;
    • Otsuka, Kojiro;
    • Fujita, Shiro;
    • Katakami, Nobuyuki;
    • Mori, Masahide;
    • Nishino, Kazumi;
    • Morita, Satoshi;
    • Negoro, Shunichi
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17

    Accuracy of epidermal growth factor receptor gene mutation analysis by direct sequencing method based on small biopsy specimens from patients with non-small cell lung cancer: analysis of results in 19 patients.

    Published in:
    International Journal of Clinical Oncology, 2008, v. 13, n. 5, p. 442, doi. 10.1007/s10147-008-0772-4
    By:
    • Masago, Katsuhiro;
    • Fujita, Shiro;
    • Mio, Tadashi;
    • Ichikawa, Masataka;
    • Sakuma, Keiichiro;
    • Young Hak Kim;
    • Hatachi, Yukimasa;
    • Fukuhara, Akiko;
    • Kamiyama, Kiyofumi;
    • Sonobe, Makoto;
    • Miyahara, Ryo;
    • Date, Hiroshi;
    • Mishima, Michiaki
    Publication type:
    Article
    18
    19
    20
    21
    22
    23

    Weekly administration of paclitaxel and carboplatin with concurrent thoracic radiation in previously untreated elderly patients with locally advanced non-small-cell lung cancer: A case series of 20 patients.

    Published in:
    Molecular & Clinical Oncology, 2014, v. 2, n. 3, p. 454, doi. 10.3892/mco.2014.249
    By:
    • JUMPEI TAKESHITA;
    • KATSUHIRO MASAGO;
    • SHIRO FUJITA;
    • AKITO HATA;
    • REIKO KAJI;
    • TAKAHISA KAWAMURA;
    • KOJI TAMAI;
    • TAKESHI MATSUMOTO;
    • KAZUMA NAGATA;
    • KYOKO OTSUKA;
    • ATSUSHI NAKAGAWA;
    • KOJIRO OTSUKA;
    • KEISUKE TOMII;
    • TAKASHI SHINTANI;
    • KENJI TAKAYAMA;
    • MASAKI KOKUBO;
    • NOBUYUKI KATAKAMI
    Publication type:
    Article
    24
    25
    26
    27

    Cover Picture: Plasma Process. Polym. 1/2007.

    Published in:
    Plasma Processes & Polymers, 2007, v. 4, n. 1, p. 1, doi. 10.1002/ppap.200790000
    By:
    • Masutani, Yasushi;
    • Nagai, Nodoka;
    • Fujita, Shiro;
    • Hayashi, Masushi;
    • Kogoma, Masuhiro;
    • Tanaka, Kunihito
    Publication type:
    Article
    28
    29

    Portal Vein Resection for Hilar Cholangiocarcinoma.

    Published in:
    American Surgeon, 2006, v. 72, n. 7, p. 599, doi. 10.1177/000313480607200706
    By:
    • Hemming, Alan W.;
    • Kim, Robin D.;
    • Mekeel, Kristin L.;
    • Fujita, Shiro;
    • Reed, Alan I.;
    • Foley, David P.;
    • Howard, Richard J.
    Publication type:
    Article
    30

    Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor: Comparison between T790M mutation-positive and mutation-negative populations.

    Published in:
    2013
    By:
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Yoshioka, Hiroshige;
    • Takeshita, Jumpei;
    • Tanaka, Kosuke;
    • Nanjo, Shigeki;
    • Fujita, Shiro;
    • Kaji, Reiko;
    • Imai, Yukihiro;
    • Monden, Kazuya;
    • Matsumoto, Takeshi;
    • Nagata, Kazuma;
    • Otsuka, Kyoko;
    • Tachikawa, Ryo;
    • Tomii, Keisuke;
    • Kunimasa, Kei;
    • Iwasaku, Masahiro;
    • Nishiyama, Akihiro;
    • Ishida, Tadashi;
    • Nishimura, Yoshihiro
    Publication type:
    Journal Article
    31

    Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 24, p. 4325, doi. 10.1002/cncr.28364
    By:
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Yoshioka, Hiroshige;
    • Takeshita, Jumpei;
    • Tanaka, Kosuke;
    • Nanjo, Shigeki;
    • Fujita, Shiro;
    • Kaji, Reiko;
    • Imai, Yukihiro;
    • Monden, Kazuya;
    • Matsumoto, Takeshi;
    • Nagata, Kazuma;
    • Otsuka, Kyoko;
    • Tachikawa, Ryo;
    • Tomii, Keisuke;
    • Kunimasa, Kei;
    • Iwasaku, Masahiro;
    • Nishiyama, Akihiro;
    • Ishida, Tadashi;
    • Nishimura, Yoshihiro
    Publication type:
    Article
    32
    33
    34
    35
    36

    Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.

    Published in:
    Cancer Science, 2017, v. 108, n. 5, p. 1000, doi. 10.1111/cas.13225
    By:
    • Hida, Toyoaki;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Ohe, Yuichiro;
    • Nokihara, Hiroshi;
    • Sakai, Hiroshi;
    • Satouchi, Miyako;
    • Nakagawa, Kazuhiko;
    • Takenoyama, Mitsuhiro;
    • Isobe, Hiroshi;
    • Fujita, Shiro;
    • Tanaka, Hiroshi;
    • Minato, Koichi;
    • Takahashi, Toshiaki;
    • Maemondo, Makoto;
    • Takeda, Koji;
    • Saka, Hideo;
    • Goto, Koichi;
    • Atagi, Shinji;
    • Hirashima, Tomonori
    Publication type:
    Article
    37
    38
    39

    Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003).

    Published in:
    2017
    By:
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Hattori, Yoshihiro;
    • Tanaka, Kosuke;
    • Fujita, Shiro;
    • Kotani, Yoshikazu;
    • Nishimura, Takashi;
    • Imamura, Fumio;
    • Yokota, Soichiro;
    • Satouchi, Miyako;
    • Monden, Kazuya;
    • Otsuka, Kojiro;
    • Nishiyama, Akihiro;
    • Tsubouchi, Kazuya;
    • Kaneda, Toshihiko;
    • Yoshioka, Hiroshige;
    • Morita, Satoshi;
    • Negoro, Shunichi
    Publication type:
    journal article
    40
    41

    A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002)

    Published in:
    2015
    By:
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Fujita, Shiro;
    • Nanjo, Shigeki;
    • Takeshita, Jumpei;
    • Tanaka, Kosuke;
    • Kaneda, Toshihiko;
    • Nishiyama, Akihiro;
    • Nishimura, Takashi;
    • Nakagawa, Atsushi;
    • Otsuka, Kojiro;
    • Morita, Satoshi;
    • Urata, Yoshiko;
    • Negoro, Shunichi
    Publication type:
    Journal Article
    42

    A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002).

    Published in:
    Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1267, doi. 10.1007/s00280-015-2755-2
    By:
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Fujita, Shiro;
    • Nanjo, Shigeki;
    • Takeshita, Jumpei;
    • Tanaka, Kosuke;
    • Kaneda, Toshihiko;
    • Nishiyama, Akihiro;
    • Nishimura, Takashi;
    • Nakagawa, Atsushi;
    • Otsuka, Kojiro;
    • Morita, Satoshi;
    • Urata, Yoshiko;
    • Negoro, Shunichi
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50